Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides

MLA

Robert Zackin, et al. “Glucose Metabolism, Lipid, and Body Fat Changes in Antiretroviral-Naive Subjects Randomized to Nelfinavir or Efavirenz plus Dual Nucleosides.” AIDS, vol. 19, Nov. 2005, pp. 1807–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....de77533a2b1e2cba3ee1e287060a2af8&authtype=sso&custid=ns315887.

APA

Robert Zackin, Pablo Tebas, Robert W. Shafer, David A Wininger, Gregory K. Robbins, Sally Snyder, Michael P. Dubé, William A. Meyer, Steven K. Grinspoon, Robert A. Parker, Ronenn Roubenoff, & Kathleen Mulligan. (2005). Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides. AIDS, 19, 1807–1818.

Chicago

Robert Zackin, Pablo Tebas, Robert W. Shafer, David A Wininger, Gregory K. Robbins, Sally Snyder, Michael P. Dubé, et al. 2005. “Glucose Metabolism, Lipid, and Body Fat Changes in Antiretroviral-Naive Subjects Randomized to Nelfinavir or Efavirenz plus Dual Nucleosides.” AIDS 19 (November): 1807–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....de77533a2b1e2cba3ee1e287060a2af8&authtype=sso&custid=ns315887.